Martin Patricia A.
Insider CIK 1916764 · CYPH Director · ANTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-10-12 | 2026-10-13 | 389 | — | $0 | 19,252 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | S Sale | 2026-09-23 | 2026-09-25 | 50,000 | $3.86 | $193.0K | 118,750 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | S Sale | 2026-09-23 | 2026-09-25 | 50,000 | $3.86 | $193.0K | 118,750 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-07-10 | 2026-07-10 | 766 | — | $0 | 18,863 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | A Award deriv | 2026-07-01 | 2026-07-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-04-10 | 2026-04-10 | 1,192 | — | $0 | 18,097 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 10,362 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 24,999 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 24,999 | — | $0 | 24,999 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 10,362 | — | $0 | 10,362 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 23,742 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | M Exercise deriv | 2026-03-13 | 2026-03-17 | 94,050 | — | $0 | 0 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | M Exercise deriv | 2026-03-13 | 2026-03-17 | 74,700 | — | $0 | 0 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | M Exercise | 2026-03-13 | 2026-03-17 | 94,050 | — | $0 | 168,750 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | M Exercise | 2026-03-13 | 2026-03-17 | 74,700 | — | $0 | 74,700 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-02-20 | 2026-02-23 | 20,400 | — | $0 | 20,400 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-01-12 | 2026-01-14 | 3,650 | — | $0 | 16,905 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | A Award deriv | 2025-12-23 | 2025-12-30 | 94,050 | — | $0 | 94,050 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | A Award deriv | 2025-11-11 | 2025-11-13 | 74,700 | — | $0 | 74,700 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-10-10 | 2025-10-14 | 3,274 | — | $0 | 13,255 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-07-10 | 2025-07-11 | 3,750 | — | $0 | 9,981 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 19,111 | — | $0 | 19,111 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-04-10 | 2025-04-11 | 3,065 | — | $0 | 6,231 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-12-19 | 2024-12-23 | 3,166 | — | $0 | 3,166 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2024-10-02 | 2024-10-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-06-19 | 2024-06-21 | 64,503 | — | $0 | 64,503 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2024-01-29 | 2024-01-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2023-08-23 | 2023-08-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 23,742 | — | $0 | 23,742 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2023-03-31 | 2023-04-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-16 | 10,362 | — | $0 | 10,362 | SEC↗ |